Nasdaq Suspends KaloBios After Shkreli Arrest
The Nasdaq Stock Market has announced it will officially suspend KaloBios Pharmaceuticals Inc. on Wednesday after halting trading in the bankrupt pharmaceutical company in the wake of former CEO Martin Shkreli's...To view the full article, register now.
Already a subscriber? Click here to view full article